Breast Cancer, Lymphedema, Neuropathy, Pain, Post Operative Pain
Conditions
Keywords
Breast cancer, persistent pain, neuropathic pain, lymphedema
Brief summary
Persistent pain, sensory disturbances, lymphedema and functional impairment are frequently occurring late effects of breast cancer treatment. The investigators have previously published data on 3253 women treated for breast cancer in Denmark in the period 2005-2006. Very few studies have examined how these late effects change in time. The aim of this study is to examine in a well defined patient population any change in the prevalence of persistent pain, sensory disturbances, lymphedema and functional impairment, as well as risk factor profile.
Interventions
None listed
Sponsors
Study design
Eligibility
Inclusion criteria
* Diagnosed with primary breast cancer between 2005-2006 * Participated in a study in 2008
Exclusion criteria
* Recurrent or new primary cancer * Metastatic cancer * Reconstructive surgery
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Prevalence of persistent pain | 6-7 years post operative | Prevalence of pain in the breast area, axilla, side of chest or arm, as a yes/no variable |
| Prevalence of patients changing pain status from the 2008 survey | 6-7 years | — |
Secondary
| Measure | Time frame |
|---|---|
| Prevalence of functional impairment | 6-7 years |
| Risk factors associated for persistent pain, sensory disturbances, lymphedema or functional impairment | 6-7 years |
| Prevalence of sensory disturbance | 6-7 years |
| Risk factors associated to changing status of sensory disturbances and lymphedema | 6-7 years post operative |
| Prevalence of patients changing status of sensory disturbances and self reported lymphedma | 6-7 years |
| Prevalence of self reported lymphedma | 6-7 years |
Countries
Denmark